Atossa Therapeutics (FRA:YAG) Cyclically Adjusted Book per Share: €53.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:YAG Atossa Therapeutics Inc FRA:YAG
34 GF Score
Price €1.93
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Cyclically Adjusted Book per Share?

Atossa Therapeutics FRA:YAG -8.10% 34 Cyclically Adjusted Book per Share is €53.74 as of Mar. 2026. GuruFocus rates FRA:YAG with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Atossa Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was €3.062. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €53.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Atossa Therapeutics's average Cyclically Adjusted Book Growth Rate was -67.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -55.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -37.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Atossa Therapeutics was -1.60% per year. The lowest was -55.50% per year. And the median was -24.40% per year.

As of today (2026-07-16), Atossa Therapeutics's current stock price is €1.93. Atossa Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €53.74. Atossa Therapeutics's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Atossa Therapeutics was 0.06. The lowest was 0.00. And the median was 0.00.


Atossa Therapeutics  (FRA:YAG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Atossa Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.93/53.74
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Atossa Therapeutics was 0.06. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Atossa Therapeutics Cyclically Adjusted Book per Share Related Terms


Atossa Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Atossa Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atossa Therapeutics Cyclically Adjusted Book per Share Chart

Atossa Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 513.75 518.66 404.97 162.48 46.78

Atossa Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.11 79.94 51.40 46.78 53.74

FRA:YAG vs QNCX, ZIVO, KTTA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Atossa Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atossa Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atossa Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Atossa Therapeutics's Cyclically Adjusted PB Ratio falls into.


FRA:YAG
34GF Score
Atossa Therapeutics Inc FRA:YAG
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Atossa Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.062/330.2130*330.2130
=3.062

Current CPI (Mar. 2026) = 330.2130.

Atossa Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 143.000 241.018 195.921
201609 229.714 241.428 314.191
201612 139.810 241.432 191.222
201703 68.048 243.801 92.167
201706 44.571 244.955 60.084
201709 27.564 246.819 36.877
201712 33.124 246.524 44.369
201803 24.102 249.554 31.892
201806 35.732 251.989 46.824
201809 24.614 252.439 32.197
201812 19.846 251.233 26.085
201903 28.378 254.202 36.864
201906 25.507 256.143 32.883
201909 22.391 256.759 28.797
201912 19.442 256.974 24.983
202003 16.192 258.115 20.715
202006 11.994 257.797 15.363
202009 12.006 260.280 15.232
202012 7.045 260.474 8.931
202103 14.568 264.877 18.161
202106 14.244 271.696 17.312
202109 14.232 274.310 17.132
202112 14.481 278.802 17.151
202203 14.537 287.504 16.696
202206 14.596 296.311 16.266
202209 14.818 296.808 16.486
202212 13.191 296.797 14.676
202303 12.530 301.836 13.708
202306 11.477 305.109 12.421
202309 11.020 307.789 11.823
202312 9.991 306.746 10.755
202403 9.430 312.332 9.970
202406 8.882 314.175 9.335
202409 7.915 315.301 8.289
202412 7.927 315.605 8.294
202503 7.017 319.799 7.246
202506 5.809 322.561 5.947
202509 4.926 324.800 5.008
202512 3.903 324.054 3.977
202603 3.062 330.213 3.062

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €53.74 mean?
Atossa Therapeutics (FRA:YAG) has a Cyclically Adjusted Book per Share of €53.74 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Atossa Therapeutics and its competitors.
Is Atossa Therapeutics' Cyclically Adjusted Book per Share too high?
Atossa Therapeutics' current Cyclically Adjusted Book per Share is €53.74. Overall, Atossa Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Atossa Therapeutics' Cyclically Adjusted Book per Share compare to QNCX and ZIVO?
Atossa Therapeutics' Cyclically Adjusted Book per Share of €53.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Atossa Therapeutics and its competitors. Atossa Therapeutics's current Cyclically Adjusted Book per Share is €53.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atossa Therapeutics stock overvalued right now?
Atossa Therapeutics (FRA:YAG) has a current Cyclically Adjusted Book per Share of €53.74. The current Cyclically Adjusted Book per Share is €53.74. Atossa Therapeutics' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Atossa Therapeutics (FRA:YAG), the current Cyclically Adjusted Book per Share is €53.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atossa Therapeutics Business Description

Other Exchanges ATOS:USAATOS:Mexico
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
34GF Score

Get the complete analysis for FRA:YAG

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.93
Price